BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang R, Yan G, Sun H, Zhang J, Song D, Kong R, Yan P, Hu P, Xie A, Wang S, Zhuang J, Yin H, Meng T, Huang Z. Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma. Biosci Rep 2020;40:BSR20201001. [PMID: 32627826 DOI: 10.1042/BSR20201001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun Y, Li Z, Wang W, Zhang X, Li W, Du G, Yin J, Xiao W, Yang H. Identification and verification of YBX3 and its regulatory gene HEIH as an oncogenic system: A multidimensional analysis in colon cancer. Front Immunol 2022;13:957865. [DOI: 10.3389/fimmu.2022.957865] [Reference Citation Analysis]
2 Xue S, Zheng T, Yan J, Ma J, Lin C, Dong S, Wei C, Li T, Zhang X, Li G. Identification of a 3-Gene Model as Prognostic Biomarker in Patients With Gastric Cancer. Front Oncol 2022;12:930586. [DOI: 10.3389/fonc.2022.930586] [Reference Citation Analysis]
3 Xu X, Ding P, Shi L, Wu G, Ma X. LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. BMC Cancer 2022;22:630. [PMID: 35676659 DOI: 10.1186/s12885-022-09680-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sahin I, George A, Seyhan AA. Therapeutic Targeting of Alternative RNA Splicing in Gastrointestinal Malignancies and Other Cancers. Int J Mol Sci 2021;22:11790. [PMID: 34769221 DOI: 10.3390/ijms222111790] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Ye P, Yang Y, Zhang L, Zheng G. Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data. Front Oncol 2021;11:658262. [PMID: 34676158 DOI: 10.3389/fonc.2021.658262] [Reference Citation Analysis]
6 Mass Sanchez PB, Krizanac M, Weiskirchen R, Asimakopoulos A. Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights. Int J Mol Sci 2021;22:5284. [PMID: 34067931 DOI: 10.3390/ijms22105284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fan X, Xie X, Yang M, Wang Y, Wu H, Deng T, Weng X, Wen W, Nie G. YBX3 Mediates the Metastasis of Nasopharyngeal Carcinoma via PI3K/AKT Signaling. Front Oncol 2021;11:617621. [PMID: 33816248 DOI: 10.3389/fonc.2021.617621] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Ma F, Wang Z, Qiang Y, Xu L, Ding P, Wang Y, Ma X. LukS-PV Inhibits Hepatocellular Carcinoma Cells Migration via the TNNC1/PI3K/AKT Axis. Onco Targets Ther 2020;13:10221-30. [PMID: 33116603 DOI: 10.2147/OTT.S278540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]